GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
+6.2%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$211M
AUM Growth
+$211M
(+72%)
Cap. Flow
+$86.7M
Cap. Flow
% of AUM
40.99%
Top 10 Holdings %
Top 10 Hldgs %
41.51%
Holding
78
New
28
Increased
12
Reduced
5
Closed
21
Top Buys
| 1 |
Edwards Lifesciences
EW
|
$8.48M |
| 2 |
CONMED
CNMD
|
$8.35M |
| 3 |
ACOR
Acorda Therapeutics, Inc.
ACOR
|
$8.29M |
| 4 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
$7.38M |
| 5 |
BLUE
bluebird bio
BLUE
|
$7.36M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$6.43M |
| 2 |
Pacific Biosciences
PACB
|
$5.95M |
| 3 |
Agios Pharmaceuticals
AGIO
|
$5.68M |
| 4 |
SAGE
Sage Therapeutics
SAGE
|
$5.13M |
| 5 |
iShares US Healthcare Providers ETF
IHF
|
$4.82M |
Sector Composition
| 1 | Healthcare | 91.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ISEE
1
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $11M | 3.17% | 215,000 +95,000 | +79% | +$4.85M |
|
|
ALXN
2
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $10.5M | 3.03% | 90,000 +50,000 | +125% | +$5.84M |
|
|
NUVA
3
DELISTED
NuVasive, Inc.
NUVA
| $8.96M | 2.59% | 150,000 +80,000 | +114% | +$4.78M |
|
4
Medtronic
MDT
$119B
| $8.68M | 2.51% | 100,000 +73,422 | +276% | +$6.37M |
|
5
BioMarin Pharmaceuticals
BMRN
$11.2B
| $8.56M | 2.47% | 110,000 +70,000 | +175% | +$5.45M |
|
|
6
Edwards Lifesciences
EW
$47.8B
| $8.48M | 2.45% | +85,000 | New | +$8.48M |
|
|
7
CONMED
CNMD
$1.68B
| $8.35M | 2.41% | +175,000 | New | +$8.35M |
|
|
ACOR
8
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $8.29M | 2.39% | +325,000 | New | +$8.29M |
|
9
Boston Scientific
BSX
$156B
| $7.6M | 2.19% | 325,000 -125,000 | -28% | -$2.92M |
|
|
SIOX
10
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $7.38M | 2.13% | +575,000 | New | +$7.38M |
|
|
BLUE
11
DELISTED
bluebird bio
BLUE
| $7.36M | 2.13% | +170,000 | New | +$7.36M |
|
12
Biogen
BIIB
$19.4B
| $7.26M | 2.1% | +30,000 | New | +$7.26M |
|
|
SPNC
13
DELISTED
Spectranetics Corp
SPNC
| $7.02M | 2.03% | 375,000 +25,000 | +7% | +$468K |
|
|
CLVS
14
DELISTED
Clovis Oncology, Inc.
CLVS
| $6.17M | 1.78% | 450,000 +431,500 | +2,332% | +$5.92M |
|
|
NVRO
15
DELISTED
NEVRO CORP.
NVRO
| $5.9M | 1.7% | 80,000 +5,000 | +7% | +$369K |
|
16
Neurocrine Biosciences
NBIX
$13.8B
| $5.68M | 1.64% | +125,000 | New | +$5.68M |
|
17
Iovance Biotherapeutics
IOVA
$807M
| $5.67M | 1.64% | 700,000 +450,000 | +180% | +$3.65M |
|
|
KTWO
18
DELISTED
K2M Group Holdings, Inc
KTWO
| $5.43M | 1.57% | +350,000 | New | +$5.43M |
|
|
GHDX
19
DELISTED
Genomic Health, Inc.
GHDX
| $5.18M | 1.5% | +200,000 | New | +$5.18M |
|
|
ELGX
20
DELISTED
Endologix Inc
ELGX
| $4.98M | 1.44% | +400,000 | New | +$4.98M |
|
21
BioCryst Pharmaceuticals
BCRX
$1.74B
| $4.83M | 1.39% | +1,700,000 | New | +$4.83M |
|
|
ITCI
22
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $4.66M | 1.35% | +120,000 | New | +$4.66M |
|
|
WMGI
23
DELISTED
Wright Medical Group Inc
WMGI
| $4.34M | 1.25% | 250,000 +125,000 | +100% | +$2.17M |
|
|
TSRO
24
DELISTED
TESARO, Inc.
TSRO
| $4.2M | 1.21% | +50,000 | New | +$4.2M |
|
|
HZNP
25
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $4.12M | 1.19% | 250,000 -175,000 | -41% | -$2.88M |
|